Loading...
menu
Search
AI Trading Bot
Features
Markets
News
Resources
Pricing
Home
ETF
SMMT
SMMT
-
Add to Watchlist
$
0.000
0.000
(
0.000%
)
At close
0.000
(
0.000%
)
Aft-market
ET
$
0.000
0.000
(
0.000%
)
At close
0.000
(
0.000%
)
Aft-market
ET
Overview
Technical
News
SMMT News
Summit Therapeutics Announces Upcoming Investor Conference Schedule
Feb 27 2026
Newsfilter
Summit Therapeutics to Participate in Upcoming Investor Conferences
Feb 26 2026
Businesswire
Summit Therapeutics Q4 2025 Earnings Call Highlights
Feb 24 2026
seekingalpha
Summit (SMMT) Q4 2025 Earnings Call Transcript
Feb 24 2026
NASDAQ.COM
Summit Therapeutics Reports Q4 Earnings Miss
Feb 23 2026
seekingalpha
US Supreme Court Strikes Down Trump's Tariff Regime
Feb 22 2026
Yahoo Finance
Summit Therapeutics Set to Announce Q4 Earnings on February 23
Feb 20 2026
seekingalpha
Summit Therapeutics to Host Q4 2025 Earnings Call
Feb 17 2026
Newsfilter
Growth Prospects for the EGFR-NSCLC Market Analyzed
Feb 11 2026
Newsfilter
Exelixis and Summit Therapeutics: Promising Drug Candidates Ahead
Feb 01 2026
NASDAQ.COM
Exelixis and Summit Therapeutics: Future Prospects
Feb 01 2026
Fool
Summit Therapeutics Grants Stock Options to New Employees
Jan 30 2026
Newsfilter
FDA Accepts Summit Therapeutics' BLA for Ivonescimab
Jan 29 2026
Benzinga
Summit Therapeutics' FDA Application Accepted for Ivonescimab
Jan 29 2026
seekingalpha
Summit Submits BLA for Ivonescimab in NSCLC
Jan 29 2026
Newsfilter
Akeso's Ivonescimab Selected as Key Drug for 2026
Jan 29 2026
Yahoo Finance
Show More News
